Endocrinology
From the Journals
Diabetes duration linked to increasing heart failure risk
Diabetes duration of 15 years or more is tied to a tripled incident heart failure rate, 20-year follow-up on nearly 10,000 U.S. adults shows.
From the Journals
Dapagliflozin safe, protective in advanced kidney disease
“This is now the absolute reassurance that we do not have to stop an SGLT2 inhibitor in people with eGFR< 30 mL/min for safety reasons” and...
From the Journals
Statins again linked to lower COVID-19 mortality
Patients hospitalized for COVID-19 who had been taking statins had a substantially lower risk of death and severe outcomes than those who weren’t...
From the Journals
Levothyroxine overprescribing common, consistent over time
A study detailing the consistent overuse of the thyroid replacement drug over a decade should be a “call to action” for doctors to stop treating...
Conference Coverage
ADA/EASD draft guidance aims to bring adults with type 1 diabetes out of shadows
The new draft ADA/EASD consensus report offers an algorithm for diagnosing type 1 diabetes, a clear call for state-of-the-art technology, and an...
From the Journals
Meta-analysis supports cardiovascular benefits of EPA
Omega-3 fatty acids improved cardiovascular outcomes, with a greater risk reduction in studies of eicosapentaenoic acid alone rather than combined...
News
New drug, finerenone, approved for slowing kidney disease in diabetes
Finerenone (Kerendia) is the first agent approved from a novel class, the nonsteroidal mineralocorticoid receptor antagonists. But its role in...
Conference Coverage
Nocturnal hypoglycemia halved with insulin degludec vs. glargine
Researchers pitted degludec against glargine U100 in the toughest patients with type 1 diabetes, those who had severe nocturnal hypoglycemia.
Conference Coverage
SUSTAIN FORTE: Higher-dose semaglutide safely boosts glycemic control, weight loss
For patients with type 2 diabetes, doubling the weekly semaglutide dose modestly improved glycemic control and weight loss while maintaining...
Conference Coverage
Unmanaged diabetes, high blood glucose tied to COVID-19 severity
Findings suggest in part that hospitalized COVID-19 patients need aggressive treatment of hyperglycemia, regardless of the diagnosis of diabetes...
News
FDA: More metformin extended-release tablets recalled